Preparation and characterization of polymer micelles from poly(ethylene glycol)-poly(D,L-lactide) block copolymers as potential drug carrier.
about
Fabrication and Characterization of Gd-DTPA-Loaded Chitosan-Poly(Acrylic Acid) Nanoparticles for Magnetic Resonance Imaging.Chrysin-loaded PLGA-PEG nanoparticles designed for enhanced effect on the breast cancer cell line.Poly(Acrylic Acid-b-Styrene) Amphiphilic Multiblock Copolymers as Building Blocks for the Assembly of Discrete Nanoparticles.Scope of nanotechnology in ovarian cancer therapeutics.Enhanced stability of polymeric micelles based on postfunctionalized poly(ethylene glycol)-b-poly(γ-propargyl L-glutamate): the substituent effectImprovement of in vivo efficacy of recombinant human erythropoietin by encapsulation in PEG-PLA micelle.Polymeric carriers for gene delivery: chitosan and poly(amidoamine) dendrimers.A cremophor-free formulation for tanespimycin (17-AAG) using PEO-b-PDLLA micelles: characterization and pharmacokinetics in rats.Doxorubicin-conjugated PLA-PEG-Folate based polymeric micelle for tumor-targeted delivery: synthesis and in vitro evaluation.Simvastatin nanoparticles attenuated intestinal ischemia/reperfusion injury by downregulating BMP4/COX-2 pathway in rats.Concepts and practices used to develop functional PLGA-based nanoparticulate systemsMultifunctional nanomicellar systems for delivering anticancer drugs.Emerging Applications of Polymersomes in Delivery: from Molecular Dynamics to Shrinkage of Tumors.Polymeric micelles with stimuli-triggering systems for advanced cancer drug targeting.Polymeric Micelles: Recent Advancements in the Delivery of Anticancer Drugs.Copolymeric micelles for delivery of EGCG and cyclopamine to pancreatic cancer cells.Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.Preparation of biodegradable PEGylated pH/reduction dual-stimuli responsive nanohydrogels for controlled release of an anti-cancer drug.The effects of acyl chain length on the micelle properties of poly(ethylene oxide)-block-poly(N-hexyl-L-aspartamide)-acyl conjugates.Synthesis and characterization of poly(L-lysine)-g-poly(D,L-lactic-co-glycolic acid) biodegradable micelles.Polymeric Micelles of Biodegradable Diblock Copolymers: Enhanced Encapsulation of Hydrophobic Drugs.Tunable stimuli-responsive self-assembly system that forms and stabilizes nanoparticles by simple mixing and heating/cooling of selected block copolymersPreparation of particulate polymeric therapeutics for medical applications
P2860
Q30924405-C283689A-B25B-40DB-A6E5-0C3E1ADFE989Q30978874-90DBC6D3-F467-42C1-AA54-5FEB50ECDD21Q33892397-20B0C927-5591-468F-A8E7-824BF8C187EBQ34075216-DE7028C3-F913-4B12-BD48-7D4A9698D014Q36070273-CDBC5408-24DF-4617-A091-626BFFEB007FQ36142527-A1270AD4-28AE-42B5-9ED6-643B6DF6E6B1Q36316919-90B01A10-290E-4BA3-9625-6BD87024EF75Q37114366-5A8659B6-E2BA-48BF-954D-DF57AA4CEA5FQ37717237-A1474A82-C369-47CD-BE92-D908E091B22EQ37739996-B3C2B643-237A-48FC-B214-1CA69B624868Q38086377-BEFB4474-A9F9-4ED9-9F0C-DDAD0850ADE5Q38119471-7FFDBE14-FFB9-49DD-9E1E-A94325790DF9Q38201455-40EAA52F-B660-4EAA-9701-62128CAA91FCQ38228139-911AAC88-F198-4609-9CB1-946B5AC5D987Q38588547-00C68671-9159-462B-8F36-56BC98395A26Q38998276-76FB98B4-B312-42B6-9153-41F38E029B93Q39841366-90457A30-EB40-4E0B-B103-3E3C92442710Q40789219-29149D60-50C9-4F6E-ABD8-2AA02337636AQ44236397-D53D6260-71ED-4383-B5FB-CEA20B1CCD2AQ44360990-A2DAD392-B4AC-426C-A700-F2B05B2EF146Q55256796-AB83F1E0-3185-4467-BFB1-2CBB555E9B2AQ57363891-E5A181A1-E4C3-4ED9-99CB-11959F6AB2EDQ57498734-31F08831-B2B5-471A-8E68-D361361653D1
P2860
Preparation and characterization of polymer micelles from poly(ethylene glycol)-poly(D,L-lactide) block copolymers as potential drug carrier.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Preparation and characterizati ...... ers as potential drug carrier.
@en
Preparation and characterizati ...... ers as potential drug carrier.
@nl
type
label
Preparation and characterizati ...... ers as potential drug carrier.
@en
Preparation and characterizati ...... ers as potential drug carrier.
@nl
prefLabel
Preparation and characterizati ...... ers as potential drug carrier.
@en
Preparation and characterizati ...... ers as potential drug carrier.
@nl
P2093
P1476
Preparation and characterizati ...... ers as potential drug carrier.
@en
P2093
P304
P356
10.1016/S0168-3659(99)00028-0
P407
P577
1999-11-01T00:00:00Z